[Federal Register Volume 89, Number 24 (Monday, February 5, 2024)]
[Notices]
[Pages 7710-7711]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-02178]



[[Page 7710]]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Center for Health Statistics, Meeting of the ICD-10 
Coordination and Maintenance Committee

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), National 
Center for Health Statistics (NCHS), Classifications and Public Health 
Data Standards Staff, announces the following meeting of the ICD-10 
Coordination and Maintenance (C&M) Committee. This meeting is open to 
the public, limited only by the number of audio lines available. Online 
registration is required.

DATES: The meeting will be held on March 19, 2024, from 9 a.m. to 5 
p.m., EDT, and March 20, 2024, from 9 a.m. to 5 p.m., EDT.

ADDRESSES: This is a virtual meeting. Register in advance at https://cms.zoomgov.com/webinar/register/WN_zqbhSXNtSEmAVWJhs4-4kA. The Webinar 
ID is 161 010 6901; the Passcode is 681647. After registering, you will 
receive a confirmation email containing information about joining the 
meeting. Further information will be provided on each of the respective 
web pages when it becomes available. For CDC, NCHS: https://www.cdc.gov/nchs/icd/icd10cm_maintenance.htm. For the Centers for 
Medicare & Medicaid Services, Department of Health and Human Services: 
https://www.cms.gov/medicare/coding-billing/icd-10-codes/icd-10-coordination-maintenance-committee-materials.

FOR FURTHER INFORMATION CONTACT: Traci Ramirez, Medical Classification 
Specialist, National Center for Health Statistics, Centers for Disease 
Control and Prevention, 3311 Toledo Road, Hyattsville, Maryland 20782-
2064. Telephone: (301) 458-4454; Email: [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The ICD-10 Coordination and Maintenance (C&M) Committee is 
a public forum for the presentation of proposed modifications to the 
International Classification of Diseases, Tenth Revision, Clinical 
Modification (CM) and ICD-10 Procedure Coding System (PCS).
    Matters to be Considered: The tentative agenda will include 
discussions on the ICD-10-CM and ICD-10-PCS topics listed below. Agenda 
items are subject to change as priorities dictate. Please refer to the 
posted agenda for updates one month prior to the meeting.
    ICD-10-PCS Topics:

1. Restriction Using Thoracoabdominal Branch Endoprosthesis *
2. Tibiotalocalcaneal Fusion with Fixation Implant *
3. Fiber Optic 3D Real-time Device Guidance **
4. Visualization and Analysis of Brain Networks in Magnetic Resonance 
Imaging *
5. Lymphatic Bypass
6. Performance of Circulatory Filtration
7. Quantitative Antimicrobial Susceptibility Testing of Blood Cultures
8. Transcatheter Tricuspid Valve Replacement *
9. Cellular Assessment via Microfluidic Deformability Cytometry **
10. Fixation of Lumbar Facet Joint
11. Extracorporeal Blood Pathogen Removal **
12. Application of prademagene zamikeracel **
13. Adoptive Immune Therapy
14. Administration of dasiglucagon
15. Drug-eluting Resorbable Scaffold System
16. Continuous Monitoring and Assessment of Vascular Blood Flow *
17. Paclitaxel-coated Balloon Catheter for Percutaneous Coronary 
Intervention
18. Division of Bioprosthetic Aortic Valve Leaflets **
19. Computer-aided Triage and Notification for Measurement of 
Intracranial Cerebrospinal Fluid Flow *
20. Implantation of Bioengineered Vessel **
21. Rapid Antimicrobial Susceptibility Testing of Blood Cultures *
22. Stereoelectroencephalographic Radiofrequency Ablation of Brain and 
Nervous Tissue
23. Insertion of Antibiotic Instilling Joint Spacer **
24. Posterior Fixation of the Thoracolumbar Spine *
25. Section X Updates
26. Addenda and Key Updates
27. Administration of bentracimab **
28. Administration of cefepime-taniborbactam *
29. Administration of ceftobiprole medocaril *
30. Administration of obecabtagene autoleucel **
31. Administration of odronextamab *
32. Administration of Orca-T **
33. Administration of RP-L201 (marnetegragene autotemcel) *
34. Administration of zanidatamab **
35. Donislecel-jujn Allogeneic Pancreatic Islet Cellular Suspension for 
Hepatic Portal Vein Infusion *

    * Requestor has submitted a new technology add-on payment (NTAP) 
application for FY 2025 consideration.
    ** Request is for an October 1, 2024, implementation date, and the 
requestor intends to submit an NTAP application for FY 2026 
consideration.
    Presentations for procedure code requests are conducted by both the 
requestor and the Centers for Medicare & Medicaid Services (CMS) during 
the C&M Committee meeting. Discussion from the requestor generally 
focuses on the clinical issues for the procedure or technology, 
followed by the proposed coding options from a CMS analyst. Topics 
presented may also include requests for new procedure codes that relate 
to a new technology add-on payment (NTAP) policy request.
    CMS has modified the approach for presenting the new NTAP-related 
ICD-10-PCS procedure code requests that involve the administration of a 
therapeutic agent. For the March 19-20, 2024, ICD-10 C&M Committee 
meeting, consistent with the requirements of section 1886(d)(5)(K)(iii) 
of the Social Security Act, applicants submitted requests to create a 
unique procedure code to describe the administration of a therapeutic 
agent, such as the option to create a new code in Section X within the 
ICD-10-PCS procedure code classification. CMS will initially display 
only those meeting materials associated with the NTAP-related ICD-10-
PCS procedure code requests that involve the administration of a 
therapeutic agent on the CMS website in early March 2024 at: https://www.cms.gov/medicare/coding-billing/icd-10-codes/icd-10-coordination-maintenance-committee-materials.
    The nine NTAP-related ICD-10-PCS procedure code requests that 
involve the administration of a therapeutic agent are:

1. Administration of bentracimab **
2. Administration of cefepime-taniborbactam *
3. Administration of ceftobiprole medocaril *
4. Administration of obecabtagene autoleucel **
5. Administration of odronextamab *
6. Administration of Orca-T **
7. Administration of RP-L201 (marnetegragene autotemcel) *
8. Administration of zanidatamab **
9. Donislecel-jujn Allogeneic Pancreatic Islet Cellular Suspension for 
Hepatic Portal Vein Infusion *

    * Requestor has submitted an NTAP application for FY 2025 
consideration.

[[Page 7711]]

    ** Request is for an October 1, 2024, implementation date, and the 
requestor intends to submit an NTAP application for FY 2026 
consideration.
    These topics will not be presented during the March 19-20, 2024, 
meeting. CMS will solicit public comments regarding any clinical 
questions or coding options included for these procedure code topics in 
advance of the meeting continuing through the end of the respective 
public comment periods. Members of the public should send any questions 
or comments to the CMS mailbox at: [email protected].
    CMS intends to post a question-and-answer document in advance of 
the meeting to address any clinical or coding questions that members of 
the public may have submitted. Following the conclusion of the meeting, 
CMS will post an updated question-and-answer document to address any 
additional clinical or coding questions that members of the public may 
have submitted during the meeting that CMS was not able to address or 
that were submitted after the meeting.
    The NTAP-related ICD-10-PCS procedure code requests that do not 
involve the administration of a therapeutic agent and all non-NTAP-
related procedure code requests will continue to be presented during 
the virtual meeting on March 19, 2024, consistent with the standard 
meeting process.
    CMS will make all meeting materials and related documents available 
at: https://www.cms.gov/medicare/coding-billing/icd-10-codes/icd-10-coordination-maintenance-committee-materials. Any inquiries related to 
the procedure code topics scheduled for the March 19, 2024, ICD-10 C&M 
Committee meeting day that are under consideration for October 1, 2024, 
implementation should be sent to the CMS mailbox at: 
[email protected].
    ICD-10-CM Topics:

1. Abnormal Anti-cyclic Citrullinated Peptide Antibody and/or 
Rheumatoid Factor Without Current or Prior Clinical Diagnosis of 
Rheumatoid Arthritis
2. APOL1-mediated Kidney Disease
3. Baked Egg Tolerance
4. Baked Milk Tolerance
5. Coding of Firearms Injuries Default
6. DLG4-related Synaptopathy
7. Flank Anatomical Specificity
8. Glutamate Receptor, Ionotropic, Gene-related Neurodevelopmental 
Disorders
9. Gulf War Illness
10. Hyperoxaluria
11. Post-exertional Malaise
12. SCN2A-related Disorders
13. SLC6A1-related Disorders
14. STXBP1-related Disorders
15. Usher Syndrome
16. Addenda

    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-02178 Filed 2-2-24; 8:45 am]
BILLING CODE 4163-18-P